Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances

被引:2
|
作者
Wang, Peng-Xin [1 ,2 ]
Mu, Xiao-Nan [3 ]
Huang, Shu-Hong [4 ]
Hu, Kang [5 ]
Sun, Zhi-Gang [1 ]
机构
[1] Shandong First Med Univ, Cent Hosp, Dept Thorac Surg, Jinan 250013, Shandong, Peoples R China
[2] Jining Med Univ, Med Coll, Jining 272067, Shandong, Peoples R China
[3] Shandong First Med Univ, Cent Hosp, Hlth Care & Geriatr Ward 1, Jinan 250013, Shandong, Peoples R China
[4] Shandong First Med Univ, Shandong Prov Hosp, Sch Clin & Basic Med Sci, Jinan 250062, Shandong, Peoples R China
[5] Soochow Univ, Suzhou Med Coll, Affiliated Hosp 1, Dept Thorac Surg, Suzhou 215000, Jiangsu, Peoples R China
关键词
Oroxylin A; Cancer; Apoptosis; Metastasis; Molecular mechanisms; Traditional Chinese medicine; NF-KAPPA-B; CHRONIC MYELOGENOUS LEUKEMIA; PPAR-GAMMA; MULTIDRUG-RESISTANCE; SIGNALING PATHWAY; P-GLYCOPROTEIN; MITOCHONDRIAL TRANSLOCATION; GLUCOSE-METABOLISM; INDUCED APOPTOSIS; CARCINOMA CELLS;
D O I
10.1016/j.ejphar.2024.176452
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Seeking an effective and safe scheme is the common goal of clinical treatment of tumor patients. In recent years, traditional Chinese medicine has attracted more and more attention in order to discover new drugs with good anti -tumor effects. Oroxylin A (OA) is a compound found in natural Oroxylum indicum and Scutellaria baicalensis Georgi plants and has been used in the treatment of various cancers. Studies have shown that OA has a wide range of powerful biological activities and plays an important role in neuroprotection, anti -inflammation, anti -virus, anti -allergy, anti -tumor and so on. OA shows high efficacy in tumor treatment. Therefore, it has attracted great attention of researchers all over the world. This review aims to discuss the anti -tumor effects of OA from the aspects of cell cycle arrest, induction of cell proliferation and apoptosis, induction of autophagy, anti -inflammation, inhibition of glycolysis, angiogenesis, invasion, metastasis and reversal of drug resistance. In addition, the safety and toxicity of the compound were also discussed. As a next step, to clarify the benefits and adverse effects of Oroxylin A in cancer patients further experiments, especially clinical trials, are needed.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies
    Mimeault, M
    Brand, RE
    Sasson, AA
    Batra, SK
    PANCREAS, 2005, 31 (04) : 301 - 316
  • [22] Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms
    Drape, Elise
    Anquetil, Typhaine
    Larrivee, Bruno
    Dubrac, Alexandre
    FRONTIERS IN HUMAN NEUROSCIENCE, 2022, 16
  • [23] RECENT ADVANCES IN CANCER THERAPY
    HAAGENSEN, CD
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1947, 23 (03) : 123 - 135
  • [24] Recent advances in the laboratory of molecular and cellular cardiology
    Breitbart, RE
    London, B
    Nguyen, HT
    Satler, CA
    ANNALS OF THORACIC SURGERY, 1995, 60 (06): : S509 - S512
  • [25] RECENT ADVANCES IN CANCER THERAPY
    Aminabee, Shaik
    Rao, Atmakuri Lakshmana
    Alimunnisa
    Begum, Shabana
    Vani, V. Bhavya Naga
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 144 - 146
  • [26] Recent advances in the molecular and cellular biology of bunyaviruses
    Walter, Cheryl T.
    Barr, John N.
    JOURNAL OF GENERAL VIROLOGY, 2011, 92 : 2467 - 2484
  • [27] Recent advances in cellular therapy for malignant lymphoma
    Tanaka, Junji
    CYTOTHERAPY, 2021, 23 (08) : 662 - 671
  • [28] Cellular and Molecular Level Mechanisms against Electrochemical Cancer Therapy
    Gu, Yeun-Hwa
    Yamashita, Takenori
    Inoue, Tota
    Song, Jin-Ho
    Kang, Ki-Mun
    JOURNAL OF PATHOGENS, 2019, 2019
  • [29] Recent advances in cellular, sub-cellular and molecular targeting
    Moghimi, SM
    Rajabi-Siahboomi, AR
    ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (02) : 129 - 133
  • [30] Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy
    Gao, Duo
    Sun, Xianlei
    Gao, Liquan
    Liu, Zhaofei
    CURRENT DRUG TARGETS, 2015, 16 (06) : 634 - 644